HOAC Virtual: Is it a melanoma? What makes a good ocular oncology referral and what to expect after treatment



Where: Online

This webinar will explore the signs, referral protocols, treatment and outcomes for patients presenting with intraocular tumours. The session will help to equip optometrists with the skills necessary to identify the features of ocular melanomas and manage the patient accordingly to achieve the best clinical outcome.

This session is part of HOAC Virtual 2021, a one day event providing education for those working in a hospital environment. For more information on the other sessions please click here.


This webinar is approved for one interactive CET point (O, DO).

To be eligible for the CET you must attend for the duration of the session. We recommend you join the session at least five minutes before the webinar is due to begin.

10:00 - 11:00

  • Is it a melanoma? What makes a good ocular oncology referral and what to expect after treatment

Learning objectives


6.1.5 Be able to identify the features of ocular melanomas and refer appropriately

Dispensing optician

8.1.5 Be aware of the implications and management of patients with ocular melanomas

Therapeutic Prescribers 



Ocular disease logo

Ocular Disease



Dispensing optician

Ocular abnormalities logo

Ocular Abnormalities


Mr Paul Rundle

Mr Paul Rundle trained in Belfast and at Wills Eye Hospital, Philadelphia, joining the team as consultant ophthalmologist in 1999. He was appointed clinical lead for ocular oncology in 2016. He has a special interest in photodynamic therapy and has developed its use in the management of eye tumours. He has lectured widely and has published research papers and textbook chapters.

Dr Katherine Sears

Dr Katharine Sears has worked in ophthalmology since 2002, and while working in the Sheffield Eye Department as a training ophthalmologist she developed an interest in the field of ocular oncology. She became a permanent member of the ocular oncology team in 2006 and has worked alongside her consultant colleagues as a speciality doctor for the past 15 years. She also has an interest in ocular inflammation and works within Sheffield’s Uveitis service.


Optelec logoOur objective is simple: Improving the quality of life of those with sight loss – reaching out with simple and effective solutions. We aim to help anyone with a sight difficulty, whether they are blind or have a degree of vision impairment, by offering simple to use and intuitive solutions. We provide assistive technology that ranges from optical magnifiers to full text to speech devices.

Our products are designed to help make the most of life: to allow staying in touch with friends and relatives, participating and succeeding in education and the workplace, and continuing to enjoy hobbies. We have four marketing leading brands that we offer; Optelec, Enhanced Vision, Freedom Scientific and Schweizer.

No7 Bio


For over 40 years, No7 Contact Lenses have driven the future of specialist contact lenses. In collaboration with industry-leading global partners, we've developed products and services that can change lives and help businesses differentiate and thrive.

With a proud history of innovation, we are inspired by a drive to give every patient the sense of health and well-being they deserve. In the 80's we introduced CNC lathing technology. By the '90s, we had developed our first aspheric GP lens. The '00s saw us launch ortho-k, hybrid and scleral designs, and more recently, we've rolled out an educational website dedicated to ECPs who fit irregular corneas.

Now established as the UK's leading manufacturer of specialist lenses, No7 looks toward an exciting future. Our experienced and knowledgeable team will continue to explore fresh opportunities, working in partnership with eye care practitioners to give every patient the chance of a happy life with healthy vision.


Menicon logoMenicon is one of the world’s largest suppliers of contact lenses. Established in 1951 in Japan, it has a presence in more than 80 countries and this year is proudly celebrating its 70th Anniversary.

The UK headquarters in Northampton is dedicated to contact lens design and manufacture from start to finish.

In 2009, the long-established British firm of David Thomas Contact Lenses was acquired, which some years earlier had taken over Nova Contact Lenses, manufacturers of Rose K, which is the most widely prescribed brand of irregular cornea lenses worldwide.

Menicon’s highest priority is eye health, using precision craftsmanship to help people see life in wonderful detail and combining the traditional values of quality, expertise and service with innovative lens design.